{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T13:36:38Z","timestamp":1785677798260,"version":"3.56.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Autoimmune pancreatitis (AIP) encompasses a heterogenous disease group that includes IgG4-related type 1 AIP and non\u2013IgG4-related type 2 AIP. Clinically and on imaging, type 2 AIP mimics type 1 AIP, other forms of chronic pancreatitis and pancreatic ductal adenocarcinoma (PDAC); therefore, discriminatory markers may aid proper diagnosis. Herein, we examine the expression of PD-L1 and indoleamine 2,3-dioxygenase (IDO1) as a diagnostic tool to distinguish type 2 AIP from other forms of pancreatitis and PDAC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>We evaluated 35 pancreatectomy specimens diagnosed with type 2 AIP and potential mimics of this disease including type 1 AIP (n=14), chronic pancreatitis-not otherwise specified (n=10), groove pancreatitis (n=14), and PDAC (n=278). We scored inflammatory infiltrates, fibrosis and atrophy and performed immunohistochemical staining for PD-L1 and IDO1. We validated our findings on a series of endoscopic ultrasound\u2013guided biopsies from patients with suspected type 2 AIP and inflammatory and neoplastic mimics of this disease (n=37).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The mean age of patients with type 2 AIP was 50 years with a F:M ratio of 1.2:1. Patients with type 2 AIP showed pancreatic ductal staining for PD-L1 and IDO1 in 69% (24\/35) and 60% (15\/25) of cases, respectively. PD-L1 reactivity was noted in 3% of patients with other forms of chronic pancreatitis and 3% of PDACs; notably, peritumoral ducts and acini were negative. Eight of 9 endoscopic ultrasound\u2013guided biopsies with pancreatic ductal epithelium from patients with type 2 AIP were positive for PD-L1, while the inflammatory and neoplastic mimics were negative. Collectively, the sensitivity and specificity of PD-L1 as a marker of type 2 AIP was 70% and 99%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Ductal PD-L1 reactivity has the potential to distinguish type 2 AIP from other forms of pancreatitis and PDAC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pas.0000000000001282","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:17:22Z","timestamp":1558754242000},"page":"898-906","source":"Crossref","is-referenced-by-count":27,"title":["Autoimmune Pancreatitis Type 2"],"prefix":"10.1097","volume":"43","author":[{"given":"Rajib","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Pathology, Upstate Medical University, Syracuse, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azfar","family":"Neyaz","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chougule","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Akita","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kobe University, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital and King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Forcione","sequence":"additional","affiliation":[{"name":"Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernandez-Del","family":"Castillo","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1056\/NEJMra061200","article-title":"Autoimmune pancreatitis","volume":"355","author":"Finkelberg","year":"2006","journal-title":"N Engl J Med"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41395-018-0146-0","article-title":"Autoimmune pancreatitis","volume":"113","author":"Nagpal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1136\/gutjnl-2015-309275","article-title":"Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience","volume":"65","author":"Hart","year":"2016","journal-title":"Gut"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/gut.41.2.263","article-title":"Non-alcoholic duct destructive chronic pancreatitis","volume":"41","author":"Ectors","year":"1997","journal-title":"Gut"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00000478-200308000-00009","article-title":"Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases","volume":"27","author":"Notohara","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2010.03.054","article-title":"Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis","volume":"139","author":"Sah","year":"2010","journal-title":"Gastroenterology"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/MPA.0b013e3182258a15","article-title":"Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey","volume":"40","author":"Kamisawa","year":"2011","journal-title":"Pancreas"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pan.2012.03.055","article-title":"Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients","volume":"12","author":"Detlefsen","year":"2012","journal-title":"Pancreatology"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00428-004-1140-z","article-title":"Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens","volume":"445","author":"Zamboni","year":"2004","journal-title":"Virchows Arch"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","article-title":"The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints","volume":"5","author":"Llosa","year":"2015","journal-title":"Cancer Discov"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2016.139","article-title":"Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13000-017-0678-4","article-title":"PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay","volume":"13","author":"Liang","year":"2018","journal-title":"Diagn Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/PAS.0000000000000891","article-title":"IL-8 expression in granulocytic epithelial lesions of idiopathic duct-centric pancreatitis (type 2 autoimmune pancreatitis)","volume":"41","author":"Ku","year":"2017","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201907000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:40:10Z","timestamp":1695422410000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201907000-00003"}},"subtitle":["Diagnostic Utility of PD-L1 Immunohistochemistry"],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001282","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}